vitamin K - essential to human health
Home  References

Vitamin K References

  1. Therapeutic Research Faculty. Vitamin K. Natural Medicines Comprehensive Database. [Online] July 7, 2016. [Cited: July 7, 2016.] http://naturaldatabase.therapeuticresearch.com/nd/Search.aspx?cs=&s=ND&pt=100&id=983&ds=&name=VITAMIN+K&searchid=23280449.
  2. King, Michael W. Blood Coagulation. Indiana University School of Medicine: The Medical Biochemistry Page. [Online] February 13, 2016. [Cited: July 7, 2016.] http://themedicalbiochemistrypage.org/blood-coagulation.html.
  3. Vitamin K Treatment Reduces Undercarboxylated Osteocalcin but Does Not Alter Bone Turnover, Density, or Geometry in Healthy Postmenopausal North American Women. Binkley, Neil, et al., et al. [ed.] Thomas L. Clemens. 6, Baltimore: John Wiley & Sons, Inc., June 2009, Journal of Bone and Mineral Research, Vol. 24, pp. 983-991. DOI: 10.1359/jbmr.081254; http://onlinelibrary.wiley.com/doi/10.1359/jbmr.081254/abstract. eISSN: 1523-4681.
  4. Higdon, Jane and Drake, Victoria J. Micronutrient Information Center: Vitamin K. Oregon State University Linus Pauling institute. [Online] August 2014. [Cited: July 8, 2016.] Last reviewed by Sarah L. Booth. http://lpi.oregonstate.edu/mic/vitamins/vitamin-K.
  5. Effect of Low Dose Vitamin K2 (MK-4) Supplementation on Bio-Indices in Postmenopausal Japanese Women. Koitaya, Noriko, et al., et al. [ed.] The Vitamin Society of Japan and Japan Society of Nutrition and Food Science. 1, Tokyo: Center for Academic Publications, April 7, 2009, Journal of Nutritional Science and Vitaminology, Vol. 55, pp. 15-21. DOI: 10.3177/jnsv.55.15; https://www.jstage.jst.go.jp/article/jnsv/55/1/55_1_15/_article. ISSN: 0022-5398.
  6. Improved Oral Anticoagulation After a Dietary Vitamin K-Guided Strategy. de Assis, Michelli C., et al., et al. [ed.] Joseph Loscalzo. 12, Boston: American Heart Association, Inc., September 22, 2009, Circulation, Vol. 120, pp. 1115-1122. DOI: 10.1161/CIRCULATIONAHA.109.849208; http://circ.ahajournals.org/content/120/12/1115. ISSN: 0009-7322.
  7. Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells. Nakaoka, Eri, et al., et al. [ed.] John G. Delinassios. 11, Kapandriti: International Institute of Anticancer Research, November 2015, Anticancer Research, Vol. 35, pp. 6041-6048. ISSN: 0250-7005.
  8. Bender, Arnold E. Dictionary of Nutrition and Food Technology. 5th. London: Butterworth & Co Ltd., 1982. ISBN: 0-408-10855-X.
  9. In vitro Growth Inhibition of Food-borne Pathogens and Food Spoilage Microorganism by Vitamin K5. Miranda, Jose M., et al., et al. [ed.] Da-Wen Sun. 6, Dublin: Springer Science+Business Media, LLC, August 2011, Food and Bioprocess Technology, Vol. 4, pp. 1060-1065. DOI: 10.1007/s11947-010-0413-6; http://link.springer.com/article/10.1007%2Fs11947-010-0413-6. ISSN: 1935-5130.
  10. Effect of vitamins other than vitamin C on viruses: Virus-inactivating activity of vitamin K5. Murata, Akira, et al., et al. [ed.] The Vitamin Society of Japan and Japan Society of Nutrition and Food Science. 6, Tokyo: Center for Academic Publications, December 1983, Journal of Nutritional Science and Vitaminology, Vol. 29, pp. 721-724. DOI: 10.3177/jnsv.29.721; https://www.jstage.jst.go.jp/article/jnsv1973/29/6/29_6_721/_article. ISSN: 0022-5398.
  11. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials. Huang, Z.-B., et al., et al. [ed.] John A. Kanis and Robert Lindsay. 3, Sheffield; West Haverstraw: Springer London, March 2015, Osteoporosis International, Vol. 26, pp. 1175-1186. DOI: 10.1007/s00198-014-2989-6; http://link.springer.com/article/10.1007%2Fs00198-014-2989-6. ISSN: 0937-941X.
  12. Natural Standard Research Collaboration. Vitamin K Natural Standard Bottom Line Monograph. Cambridge: Natural Standard Inc., 2008. Monograph.
  13. Schick, Paul. Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency . Medscape. [Online] April 6, 2016. [Cited: July 13, 2016.] http://emedicine.medscape.com/article/200390-overview#showall.
  14. Ehrlich, Steven D. Vitamin K. University of Maryland Medical Center Complementary and Alternative Medicine Guide. [Online] July 16, 2013. [Cited: July 13, 2016.] http://umm.edu/health/medical/altmed/supplement/vitamin-k.
  15. Adverse effects of herbal or dietary supplements in G6PD deficiency: a systematic review. Lee, Shaun Wen Huey, et al., et al. [ed.] Adam F. Cohen. Leiden: John Wiley & Sons, Inc.: The British Pharmacological Society, May 21, 2016, British Journal of Clinical Pharmacology, Vol. Early View (Online Version of Record published before inclusion in an issue). DOI: 10.1111/bcp.12976; http://onlinelibrary.wiley.com/doi/10.1111/bcp.12976/abstract. ISSN: 0306-5251.
  16. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Schurgers, Leon J., et al., et al. [ed.] Sanford J. Shattil. 8, La Jolla: The American Society of Hematology, April 15, 2007, Blood, Vol. 09, pp. 3279-3283. DOI: 10.1182/blood-2006-08-040709;http://www.bloodjournal.org/content/109/8/3279. ISSN: 0006-4971.
  17. Marcovitch, Harvey. Black's Medical Dictionary. 41. London: A & C Black Publishers Limited, 2005. ISBN: 0-7136-6146-1.
  18. U.S. National Library of Medicine. Alpha-1 Antitrypsin Deficiency. Medline Plus. [Online] August 1, 2014. [Cited: July 13, 2016.] https://medlineplus.gov/alpha1antitrypsindeficiency.html.
  19. Vitamin K deficiency bleeding in cholestatic infants with alpha-1-antitrypsin deficiency. Hasselt, P.M. van, et al., et al. [ed.] Howard Bauchner. 6, Boston: BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health, November 2009, ADC Fetal & Neonatal Edition, Vol. 94, pp. F456-460. DOI: 10.1136/adc.2008.148239; http://fn.bmj.com/content/94/6/F456. eISSN: 1468-2052.
  20. Cholestasis in the newborn and infant. Fischler, Björn and Lamireau, Thierry. [ed.] Raoul Poupon. 3, Paris: Elsevier Masson SAS, June 2014, Clinics and Research in Hepatology and Gastroenterology, Vol. 38, pp. 263-267. DOI: 10.1016/j.clinre.2014.03.010; http://www.sciencedirect.com/science/article/pii/S2210740114000655. ISSN: 2210-7401.
  21. Garcia, Andrea A. and Reitsma, Pieter H. VKORC1 and the Vitamin K Cycle. [ed.] Gerald Litwack. Vitamin K. London: Elsevier: Academic Press, 2008, Vol. 78, 2, pp. 23-34.
  22. Bates, C.J. Vitamin K. [ed.] Benjamin Caballero. Guide to Nutritional Supplements. Oxford: Elsevier Ltd., 2009, pp. 486-494.
  23. Bellido-Martín, Lola and Frutos, Pablo García de. Vitamin K-Dependent Actions of Gas6. [ed.] Gerald Litwack. Vitamin K. London: Elsevier: Academic Press, 2008, Vol. 78, 9, pp. 185-209.
  24. Vitamin K and Sphingolipid Metabolism: Evidence to Date. Denisova, Natalia A. and Booth, Sarah L. [ed.] Robert M. Russell. 4, Boston: Wiley: International Life Sciences Institute, April 2005, Nutrition Reviews, Vol. 63, pp. 111-121. DOI: 10.1111/j.1753-4887.2005.tb00129.x; http://nutritionreviews.oxfordjournals.org/content/63/4/111. ISSN: 0029-6643.
  25. Vitamin K2 suppresses malignancy of HuH7 hepatoma cells via inhibition of connexin 43. Kaneda, M., et al., et al. [ed.] Manfred Schwab. 1, Heidelberg: Elsevier Ireland Ltd., May 8, 2008, Cancer Letters, Vol. 263, pp. 53-60. DOI: 10.1016/j.canlet.2007.12.019; http://www.cancerletters.info/article/S0304-3835(07)00628-3/abstract. ISSN: 0304-3835.
  26. Vitamin K3 Attenuates Cerulein-Induced Acute Pancreatitis Through Inhibition of the Autophagic Pathway. Chinzei, Ryo, et al., et al. [ed.] Vay Liang W. Go. 1, Los Angeles: Wolters Kluwer Health, Inc., January 28, 2011, Pancreas: Journal of Neuroendocrine Tumors and Pancreatic Diseases and Sciences, Vol. 40, pp. 84-94. DOI: 10.1097/MPA.0b013e3181f69fc9; http://journals.lww.com/pancreasjournal/pages/articleviewer.aspx?year=2011&issue=01000&article=00017&type=abstract. ISSN: 0885-3177.
  27. Novel Role of Vitamin K in Preventing Oxidative Injury to Developing Oligodendrocytes and Neurons. Li, Jianrong, et al., et al. [ed.] Gary Westbrook. 13, Chicago: Society for Neuroscience, July 2, 2003, The Journal of Neuroscience, Vol. 23, pp. 5816-5826. ISSN: 0270-6474.
  28. Parkinson's Disease as Multifactorial Oxidative Neurodegeneration: Implications for Integrative Management. Kidd, Parris M. [ed.] Timothy Birdsall. 6, Napa: Thorne Research, Inc., 2000, Alternative Medicine Review, Vol. 5, pp. 502-529. ISSN: 1089-5159.
  29. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Sconce, Elizabeth, et al., et al. [ed.] Sanford J. Shattil. 6, Bethesda: The American Society of Hematology, September 15, 2007, Blood, Vol. 109, pp. 2419-2423. DOI: 10.1182/blood-2006-09-049262; http://www.bloodjournal.org/content/109/6/2419. ISSN: 0006-4971.
  30. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. Morishita, Minoru, et al., et al. [ed.] Duncan Alexander Gordon. 3, Toronto : Highwire Press, March 2008, The Journal of Rheumatology, Vol. 35, pp. 407-413. ISSN: 0315-162X.
  31. Vitamin K Dependent Proteins and the Role of Vitamin K2 in the Modulation of Vascular Calcification: A Review. El Asmar, Margueritta S., Naoum, Joseph J. and Arbid, Elias J. [ed.] Ibrahim Al-Zakwani. 3, Muscat: Oman Medical Specialty Board, May 2014, Oman Medical Journal, Vol. 29, pp. 172-177. PMCID: PMC4052396. ISSN: 1999-768x.
  32. The effects of topical vitamin K on bruising after laser treatment. Shah, Neha S., et al., et al. [ed.] Jeffrey D. Bernhard. 2, Shrewsbury: Elsevier Inc., August 2002, Journal of the American Academy of Dermatology, Vol. 47, pp. 241-244. DOI: 10.1016/S0190-9622(02)00053-1; http://www.jaad.org/article/S0190-9622(02)00053-1/abstract. ISSN: 0190-9622.
  33. Testolactone, sulindac, warfarin, and vitamin k1 for unresectable desmoid tumors. Waddell, William R. and Kirsch, Wolff M. [ed.] Jr. Hiram C. Polk. 4, Louisville: Elsevier Inc., April 1991, The American Journal of Surgery , Vol. 161, pp. 416-421. DOI: 10.1016/0002-9610(91)91102-O; http://www.americanjournalofsurgery.com/article/0002-9610(91)91102-O/abstract. ISSN: 0002-9610.
  34. Effect of Vitamin K Supplementation on Insulin Resistance in Older Men and Women. Yoshida, Makiko, et al., et al. [ed.] Vivian A. Fonseca. 11, Alexandria: American Diabetes Association, November 2008, Diabetes Care, Vol. 31, pp. 2092-2096. DOI: 10.2337/dc08-1204; http://care.diabetesjournals.org/content/31/11/2092. ISSN: 0149-5992.
  35. Vitamin K Acupuncture Point Injection for Severe Primary Dysmenorrhea: An International Pilot Study. Wang, Li, et al., et al. [ed.] George D. Lundberg. 4, New York: WebMD LLC, December 27, 2004, Medscape General Medicine, Vol. 6, p. 45. PMCID: PMC1480551. ISSN: 1531-0132.
  36. Acupuncture point injection treatment of primary dysmenorrhoea: a randomised, double blind, controlled study. Wade, C., et al., et al. [ed.] Trish Groves. 1, London: BMJ Publishing Group Ltd., January 5, 2016, BMJ Open, Vol. 6, p. e008166. DOI: 10.1136/bmjopen-2015-008166; http://bmjopen.bmj.com/content/6/1/e008166. ISSN: 2044-6055.
  37. Menadione (vitamin K) enhances the antibiotic activity of drugs by cell membrane permeabilization mechanism. Andrade, Jacqueline C., et al., et al. [ed.] Abdullah S. Alhomida. Riyadh: Elsevier B.V.: King Saud University, October 21, 2015, Saudi Journal of Biological Sciences, Vol. In press. DOI: 10.1016/j.sjbs.2015.09.004; http://www.sciencedirect.com/science/article/pii/S1319562X15001990. ISSN: 1319-562X.
  38. Vitamin K Status and Mortality After Kidney Transplantation: A Cohort Study. Keyzer, Charlotte A., et al., et al. [ed.] Andrew S. Levey. 3, Boston: Elsevier B.V., March 2015, American Journal of Kidney Diseases, Vol. 65, pp. 474-483. DOI: 10.1053/j.ajkd.2014.09.014; http://www.ajkd.org/article/S0272-6386(14)01277-3/abstract. ISSN: 0272-6386.
  39. Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma. Yoshiji, Hitoshi, et al., et al. [ed.] Massimo Colombo. 2, Milan: Elsevier Inc.: European Association for the Study of the Liver, August 2009, Journal of Hepatology, Vol. 51, pp. 315-321. DOI: 10.1016/j.jhep.2009.04.011; http://www.journal-of-hepatology.eu/article/S0168-8278(09)00318-3/abstract. ISSN: 0168-8278.
  40. Friedman, Roberta. Vitamin K Therapy Slows Spread of Liver Cancer: Presented at DDW. Doctor's Guide Publishing Limited. [Online] May 29, 2002. [Cited: July 18, 2016.] http://www.docguide.com/vitamin-k-therapy-slows-spread-liver-cancer-presented-ddw.
  41. Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Nimptsch, Katharina, et al., et al. [ed.] Dennis M. Bier. 5, Houston: American Society for Nutrition, March 24, 2010, American Journal of Clinical Nutrition, Vol. 91, pp. 1348-1358. DOI: 10.3945/ajcn.2009.28691; http://ajcn.nutrition.org/content/91/5/1348. ISSN: 0002-9165.
  42. Mayo Clinic. Vitamin K May Protect Against Developing Non-Hodgkin's Lymphoma, Say Mayo Clinic Researchers. ScienceDaily. [Online] April 21, 2010. [Cited: August 8, 2016.] https://www.sciencedaily.com/releases/2010/04/100419151117.htm.
  43. The Utility of Vitamin K3 (Menadione) against Pancreatic Cancer. Osada, Shinji, et al., et al. [ed.] Gen-Ichiro Soma. 1A, Takamatsu: The International Institute of Anticancer Research, January 1, 2008, Anticancer Research, Vol. 28, pp. 45-50. ISSN: 0250-7005.
  44. A 12 Week, Open Label, Phase I/IIa Study Using Apatone® for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy. Tareen, Basir, et al., et al. [ed.] Dennis D. Taub. 2, Washington, DC: Ivyspring International Publisher, March 24, 2008, International Journal of Medical Sciences, Vol. 5, pp. 62-67. DOI: 10.7150/ijms.5.62; http://www.medsci.org/v05p0062.htm. ISSN: 1449-1907.
  45. Pilot Clinical Trial on the Efficacy of Prophylactic Use of Vitamin K1-Based Cream (Vigorskin) to Prevent Cetuximab-Induced Skin Rash in Patients With Metastatic Colorectal Cancer. Pinta, Francesco, et al., et al. [ed.] Edward Chu. 1, Pittsburgh: Elsevier Inc., March 2014, Clinical Colorectal Cancer, Vol. 13, pp. 62-67. DOI: 10.1016/j.clcc.2013.10.001; http://www.clinical-colorectal-cancer.com/article/S1533-0028(13)00117-5/abstract. ISSN: 1533-0028.
  46. Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study. Lanzillo, Roberta, et al., et al. [ed.] Alan Thompson. 9, London: SAGE Publications, August 2015, Multiple Sclerosis Journal, Vol. 21, pp. 1215-1218. DOI: 10.1177/1352458514562989; http://msj.sagepub.com/content/21/9/1215. ISSN: 1352-4585.
  47. Evaluation of the clinical efficacy and safety of an eye counter pad containing caffeine and vitamin K in emulsified Emu oil base. Ahmadraji, Fatemeh and Shatalebi, Mohammad Ali. [ed.] Shaghayegh Haghjooy Javanmard. 10, Isfahan: Wolters Kluwer - Medknow, January 6, 2015, Advanced Biomedical Research, Vol. 4. DOI: 10.4103/2277-9175.148292; http://www.advbiores.net/article.asp?issn=2277-9175;year=2015;volume=4;issue=1;spage=10;epage=10;aulast=Ahmadraji. eISSN: 2277-9175.
  48. Dietary Intake of Vitamin K Is Inversely Associated with Mortality Risk. Juanola-Falgarona, Martí, et al., et al. [ed.] Teresa A. Davis. 5, Houston: American Society for Nutrition, May 1, 2014, Journal of Nutrition, Vol. 144, pp. 743-750. DOI: 10.3945/jn.113.187740; http://jn.nutrition.org/content/144/5/743. ISSN: 0022-3166.
  49. National Digestive Diseases Information Clearinghouse. Pancreatitis. National Institute of Diabetes and Digestive and Kidney Diseases. [Online] August 2012. [Cited: July 21, 2016.] https://www.niddk.nih.gov/health-information/health-topics/liver-disease/pancreatitis/Pages/facts.aspx. NIH Publication No. 08-1596.
  50. The Role of Vitamin K in Soft-Tissue Calcification. Theuwissen, Elke, Smit, Egbert and Vermeer, Cees. [ed.] John W. Suttie. 2, Madison: American Society for Nutrition, March 2012, Advances in Nutrition, Vol. 3, pp. 166-173. DOI: 10.3945/an.111.001628; http://advances.nutrition.org/content/3/2/166. eISSN: 2156-5376.
  51. Potential role of vitamin K in radiological progression of early knee osteoarthritis patients. El-Brashy, Abd-El Wahab S., et al., et al. [ed.] Tamer A Gheita. 3, Cairo: Elsevier B.V.: Egyptian Society for Joint Diseases and Arthritis, July 2016, The Egyptian Rheumatologist, Vol. 38, pp. 217-223. DOI: 10.1016/j.ejr.2016.03.001; http://www.sciencedirect.com/science/article/pii/S1110116416300047. ISSN: 1110-1164.
  52. The association between vitamin K status and knee osteoarthritis features in older adults: The Health, Aging and Body Composition Study. Shea, M.K., et al., et al. [ed.] Joel Block. 3, Chicago: Elsevier: OsteoArthritis Research Society International, March 2015, Osteoarthritis and Cartilage, Vol. 23, pp. 370-378. DOI: 10.1016/j.joca.2014.12.008; http://www.oarsijournal.com/article/S1063-4584(14)01380-6/abstract. ISSN: 1063-4584.
  53. Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial. Holick, Michael F., et al., et al. [ed.] Yoshiki Seino. 3, Osaka: Springer Japan; Japanese Society for Bone and Mineral Research, May 2010, Journal of Bone and Mineral Metabolism, Vol. 28, pp. 342-350. DOI: 10.1007/s00774-009-0141-z; http://link.springer.com/article/10.1007%2Fs00774-009-0141-z. ISSN: 0914-8779.
  54. Response of Serum Carboxylated and Undercarboxylated Osteocalcin to Risedronate Monotherapy and Combined Therapy with Vitamin K2 in Corticosteroid-Treated Patients: A Pilot Study. Hozuki, Takayoshi, et al., et al. [ed.] The Japanese Society of Internal Medicine. 5, Tokyo: Kyorinsha Co., Ltd., March 1, 2010, Internal Medicine, Vol. 49, pp. 371-376. DOI: 10.2169/internalmedicine.49.2551; https://www.jstage.jst.go.jp/article/internalmedicine/49/5/49_5_371/_article. ISSN: 0918-2918.
  55. Dietary vitamin K2 supplement improves bone status after lung and heart transplantation. Forli, Liv, et al., et al. [ed.] Manikkam Suthanthiran and Kathryn J. Wood. 4, New York; Oxford: Lippincott Williams & Wilkins, February 27, 2010, Transplantation, Vol. 89, pp. 458-464. DOI: 10.1097/TP.0b013e3181c46b69; http://journals.lww.com/transplantjournal/pages/articleviewer.aspx?year=2010&issue=02270&article=00014&type=abstract. ISSN: 0041-1337.
  56. Vitamin K Supplement Along with Vitamin D and Calcium Reduced Serum Concentration of Undercarboxylated Osteocalcin While Increasing Bone Mineral Density in Korean Postmenopausal Women over Sixty-Years-Old. Je, Sang Hyeon, et al., et al. [ed.] Sung-Tae Hong. 8, Seoul: The Korean Academy of Medical Sciences, August 2011, Journal of Korean Medicine, Vol. 26, pp. 1093-1098. DOI: 10.3346/jkms.2011.26.8.1093 ; http://synapse.koreamed.org/DOIx.php?id=10.3346/jkms.2011.26.8.1093. ISSN: 1011-8934.
  57. Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver; Vitamin K2 for Cirrhosis-Associated Bone Disease. Shiomi, S., et al., et al. [ed.] Eamonn M.M. Quigley. 4, s.l.: Nature Publishing Group: American College of Gastroenterology, April 2002, The American Journal of Gastroenterology, Vol. 97, pp. 978-981. DOI: 10.1111/j.1572-0241.2002.05618.x; http://www.nature.com/ajg/journal/v97/n4/full/ajg2002237a.html. ISSN: 0002-9270.
  58. National Cancer Institute. Myelodysplastic Syndromes Treatment (PDQ®): General Information About Myelodysplastic Syndromes. U.S. National Institutes of Health. [Online] August 12, 2015. [Cited: July 22, 2016.] http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq#section/all.
  59. The Leukemia & Lymphoma Society. Acute Myeloid Leukemia. The Leukemia & Lymphoma Society. [Online] September 2, 2010. [Cited: July 22, 2016.] http://www.lls.org/leukemia/acute-myeloid-leukemia.
  60. Multicenter phase II trial of vitamin K(2) monotherapy and vitamin K(2) plus 1alpha-hydroxyvitamin D(3) combination therapy for low-risk myelodysplastic syndromes. Akiyama, Nobu, et al., et al. [ed.] John M. Bennett and Terry J. Hamblin. 9, Rochester; Bournemouth: Elsevier Ltd., September 2010, Leukemia Research, Vol. 34, pp. 1151-1157. DOI: 10.1016/j.leukres.2010.04.006; http://www.lrjournal.com/article/S0145-2126(10)00208-0/abstract. ISSN: 0145-2126.
  61. Lenroot, Rhoshel K. and Giedd, Jay N. The Structural Development of the Human Brain as Measured Longitudinally with Magnetic Resonance Imaging. [ed.] Donna Coch, Kurt W. Fischer and Geraldine Dawson. Human Behavior, Learning, and the Developing Brain: Typical Development. New York: Guilford Press, 2010, 3, pp. 50-73. ISBN: 978-1-60623-968-1.
  62. Bartzokis, G. and Lu, P.H. Brain Volume: Age-Related Changes. [ed.] Patrick R. Hof and Charles V. Mobbs. Handbook of the Neuroscience of Aging. London: Elsevier: Academic Press, 2009, pp. 27-38. ISBN: 978-0-12374-898-0.
  63. American Association for Clinical Chemistry. PT and INR. Lab Tests Online. [Online] August 14, 2015. [Cited: July 23, 2016.] http://www.labtestsonline.org/understanding/analytes/pt/test.html.
  64. An audit of the role of vitamin K in the reversal of International Normalised Ratio (INR) in patients undergoing surgery for hip fracture. Bhatia, Maneesh, et al., et al. [ed.] Colin Johnson. 6, London: The Royal College of Surgeons of England, September 2010, Annals, Vol. 92, pp. 473-476. DOI: 10.1308/003588410X12664192075774; http://publishing.rcseng.ac.uk/doi/10.1308/003588410X12664192075774. ISSN: 0035-8843.
  65. Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?. Steib, A., et al., et al. [ed.] Michael Greaves and David Lane. 3, Aberdeen; London: John Wiley & Sons, Inc.: International Society on Thrombosis and Haemostasis, March 2010, Journal of Thrombosis and Haemostasis, Vol. 8, pp. 499-503. DOI: 10.1111/j.1538-7836.2009.03685.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2009.03685.x/abstract. eISSN: 1538-7836.
  66. Nanda, Rita, Zieve, David and Ogilvie, Isla. Factor II Deficiency. Medline Plus Medical Encyclopedia. [Online] January 1, 2015. [Cited: July 25, 2016.] https://medlineplus.gov/ency/article/000549.htm.
  67. CDC25A Phosphatase: a Rate-Limiting Oncogene That Determines Genomic Stability. Ray, Dipankar and Kiyokawa, Hiroaki. [ed.] George C. Prendergast. 5, Wynnewood: American Association for Cancer Research, March 1, 2008, Cancer Research, Vol. 68, pp. 1251-1253. DOI: 10.1158/0008-5472.CAN-07-5983; http://cancerres.aacrjournals.org/content/68/5/1251. ISSN: 0008-5472.
  68. Significance of Des-gamma-carboxy Prothrombin Production in Hepatocellular Carcinoma. Fujikawa, Tatsuya, Shiraha, Hidenori and Yamamoto, Kazuhide. [ed.] Masao Yamada. 6, Okayama: Okayama University Medical School, December 2009, Acta Medica Okayama, Vol. 63, pp. 299-304. ISSN: 0386-300X.
  69. Vitamins C and K3 Sensitize Human Urothelial Tumors to Gemcitabine. Kassouf, Wassim, et al., et al. [ed.] William D. Steers. 4, Charlottesville: Elsevier Inc., October 2006, The Journal of Urology, Vol. 176, pp. 1642-1647. DOI: 10.1016/j.juro.2006.06.042; http://www.jurology.com/article/S0022-5347(06)01418-2/abstract. ISSN: 0022-5347.
  70. Masuda, K. Nakayal Y., Aiuchi, T. and Itabe, H. Vitamin K2 as a Chemotherapeutic Agent for Treating Ovarian Cancer. [ed.] Samir Farghaly. Ovarian Cancer - Clinical and Therapeutic Perspectives. Rijeka: InTech, 2012, 13, pp. 259-274. ISBN: 978-953-307-810-6.
  71. Vitamin K2. Thorne Research, Inc. [ed.] Kathleen A. Head. 3, Napa: Thorne Research, Inc., 2009, Alternative Medicine Review, Vol. 14, pp. 284-293. ISSN: 1089-5159.
  72. Role of Vitamin K2 in the Development of Hepatocellular Carcinoma in Women With Viral Cirrhosis of the Liver. Habu, Daiki, et al., et al. [ed.] Catherine D. DeAngelis. 3, Baltimore: American Medical Association, July 21, 2004, JAMA, Vol. 292, pp. 358-361. DOI: 10.1001/jama.292.3.358; http://jama.jamanetwork.com/article.aspx?articleid=199121. ISSN: 0098-7484.
  73. Naturally occurring K vitamins inhibit pancreatic cancer cell survival through a caspase-dependent pathway. Showalter, Shayna L, et al., et al. [ed.] Mamoru Watanabe. 4, Tokyo: Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd, April 2010, Journal of Gastroenterology and Hepatology, Vol. 25, pp. 738-744. DOI: 10.1111/j.1440-1746.2009.06085.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1746.2009.06085.x/abstract. eISSN: 1440-1746.
  74. In Vivo Reactivation of DNases in Implanted Human Prostate Tumors After Administration of a Vitamin C/K3 Combination. Taper, Henryk S., et al., et al. [ed.] Denis G. Baskin. 1, Seattle: SAGE Publications: The Histochemical Society, January 2001, Journal of Histochemistry & Cytochemistry, Vol. 49, pp. 109-119. ISSN: 0022-1554.
  75. Poon, Ronnie T. Research on Angiogenesis in Liver Cancer and its Clinical Implications. [ed.] Felix Lee. Liver Cancer: New Research. New York: Nova Science Publishers, Inc., 2006, 10, pp. 227-251. ISBN: 1-59454-182-5.
  76. Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Stickel, Felix and Hellerbrand, Claus. [ed.] Emad El-Omar. 10, Aberdeen: BMJ Publishing Group Ltd & British Society of Gastroenterology, July 21, 2010, Gut, Vol. 59, pp. 1303-1307. DOI: 10.1136/gut.2009.199661; http://gut.bmj.com/content/59/10/1303. eISSN: 1468-3288.
  77. Synergistic Effect of Sorafenib and Vitamin K on Suppression of Hepatocellular Carcinoma Cell Migration and Metastasis. Ha, Tae-Yong, et al., et al. [ed.] John G. Delinasios. 4, Highlands: The International Institute of Anticancer Research, April 2015, Anticancer Research, Vol. 35, pp. 1985-1995. ISSN: 0250-7005.
  78. CDC25A Phosphatase: a Rate-Limiting Oncogene That Determines Genomic Stability. Ray, Dipankar and Kiyokawa, Hiroaki. [ed.] George C. Prendergast. 5, Wynnewood: American Association for Cancer Research, March 1, 2008, Cancer Research, Vol. 68, pp. 1251-1253. DOI: 10.1158/0008-5472.CAN-07-5983; http://cancerres.aacrjournals.org/content/68/5/1251. ISSN: 0008-5472.
  79. Pancreatic cancer surgery: past, present, and future. Griffin, James F., Poruk, Katherine E. and Wolfgang, Christopher L. [ed.] Yang Ke. 4, Peking: AME Publishing Company: Chinese Anti-Cancer Association, August 2015, Chinese Journal of Cancer Research, Vol. 27, pp. 332-348. DOI: 10.3978/j.issn.1000-9604.2015.06.07; http://cjcr.amegroups.com/article/view/7075/7997. ISSN: 1000-9604.
  80. Role of Anticoagulation in the Management of Pancreatic Cancer. Sohail, Muhammad Adnan and Saif, Muhammad Wasif. [ed.] Alan Lefor, Ashraf Mustafa Rasheed and Muhammad Wasif Saif. 2, Shimotsuke; Cardiff; Boston: iMedPub, March 9, 2009, Journal of the Pancreas, Vol. 10, pp. 82-87. ISSN: 1590-8577.
  81. Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways. Wei, Gang, Wang, Meifang and Carr, Brian I. [ed.] Gary S. Stein, Harvey M. Florman and Constance E. Brinckerhoff. 1, Burlington; Worcester; Dartmouth: Wiley Periodicals, Inc., July 2010, Journal of Cellular Physiology, Vol. 224, pp. 112-119. DOI: 10.1002/jcp.22099; http://onlinelibrary.wiley.com/doi/10.1002/jcp.22099/abstract. eISSN: 1097-4652.
  82. Vitamin K: The missing link to prostate health. Donaldson, Michael S. [ed.] Mehar Manku. 3, Birmingham: Elsevier Ltd., March 2015, Medical Hypotheses, Vol. 84, pp. 219-222. DOI: 10.1016/j.mehy.2014.12.028; http://www.medical-hypotheses.com/article/S0306-9877(15)00011-0/abstract. ISSN: 0306-9877.
  83. Cancer risk in long-term users of vitamin K antagonists: A population-based case-control study. Pottegård, Anton, Friis, Søren and Hallas, Jesper. [ed.] Peter Lichter. 11, DKFZ, Germany: John Wiley & Sons, Inc.: UICC, June 1, 2013, International Journal of Cancer, Vol. 132, pp. 2606-2612. DOI: 10.1002/ijc.27905; http://onlinelibrary.wiley.com/doi/10.1002/ijc.27905/abstract. ISSN: 1097-0215.
  84. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Nimptsch, Katharina, Rohrmann, Sabine and Linseisen, Jakob. [ed.] Dennis M. Bier. 4, Houston: American Society for Nutrition, April 1, 2008, American Journal of Clinical Nutrition, Vol. 87, pp. 985-992. ISSN: 0002-9165.
  85. Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism. Movahed, Ali, et al., et al. [ed.] Yoshiki Seino. 6, Osaka: Springer Japan; Japanese Society for Bone and Mineral Research, November 2012, Journal of Bone and Mineral Metabolism, Vol. 30, pp. 683-691. DOI: 10.1007/s00774-012-0367-z; http://link.springer.com/article/10.1007%2Fs00774-012-0367-z. ISSN: 0914-8779.
  86. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Shea, M. Kyla, et al., et al. [ed.] Dennis M. Bier. 6, Houston: American Society for Nutrition, April 22, 2009, American Journal of Clinical Nutrition, Vol. 89, pp. 1799-1807. DOI: 10.3945/ajcn.2008.27338; http://ajcn.nutrition.org/content/89/6/1799. ISSN: 0002-9165.
  87. Effect of Vitamin K2 Supplementation on Functional Vitamin K Deficiency in Hemodialysis Patients: A Randomized Trial. Westenfeld, Ralf, et al., et al. [ed.] Andrew S. Levey. 2, Boston: Elsevier Inc., February 2012, American Journal of Kidney Diseases, Vol. 59, pp. 186-195. DOI: 10.1053/j.ajkd.2011.10.041; http://www.ajkd.org/article/S0272-6386(11)01570-8/abstract. ISSN: 0272-6386.
  88. Matrix Gla Protein Species and Risk of Cardiovascular Events in Type 2 Diabetic Patients. Dalmeijer, Geertje W., et al., et al. [ed.] William T. Cefalu. 11, Alexandria: American Diabetes Association, November 2013, Diabetes Care, Vol. 36, pp. 3766-3771. DOI: 10.2337/dc13-0065; http://care.diabetesjournals.org/content/36/11/3766. ISSN: 0149-5992.
  89. Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of Atherosclerosis. Shea, M. Kyla, et al., et al. [ed.] Dennis M. Bier. 1, Houston: American Society for Nutrition, July 2013, American Journal of Clinical Nutrition, Vol. 98, pp. 197-208. DOI: 10.3945/ajcn.112.056101; http://ajcn.nutrition.org/content/98/1/197. ISSN: 0002-9165.
  90. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. Delanaye, Pierre, et al., et al. [ed.] Hayley Henderson. 145, Liverpool: BioMed Central Ltd., September 4, 2014, BMC Nephrology, Vol. 15. DOI: 10.1186/1471-2369-15-145; https://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-15-145. ISSN: 1471-2369.
  91. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study. Pivin, Edward, et al., et al. [ed.] Anna F. Dominiczak. 1, Glasgow: American Heart Association, Inc., July 2015, Hypertension, Vol. 66, pp. 85-92. DOI: 10.1161/HYPERTENSIONAHA.115.05177; http://hyper.ahajournals.org/content/66/1/85. ISSN: 0194-911X.
  92. Circulating Uncarboxylated Matrix Gla Protein Is Associated with Vitamin K Nutritional Status, but Not Coronary Artery Calcium, in Older Adults. Shea, M. Kyla, et al., et al. [ed.] A. Catharine Ross. 8, University Park: American Society for Nutrition, August 1, 2011, Journal of Nutrition, Vol. 141, pp. 1529-1534. DOI: 10.3945/jn.111.139634; http://jn.nutrition.org/content/141/8/1529. ISSN: 0022-3166.
  93. Coronary artery calcification is associated with high serum concentration of undercarboxylated osteocalcin in asymptomatic Korean men. Choi, Beom-hee, et al., et al. [ed.] S.G. Ball and J. Newell-Price. 3, Newcastle; Sheffield: John Wiley & Sons, Inc.: The Society for Endocrinology, September 2015, Clinical Endocrinology, Vol. 83, pp. 320-326. DOI: 10.1111/cen.12792; http://onlinelibrary.wiley.com/doi/10.1111/cen.12792/abstract. eISSN: 1365-2265.
  94. Relationship of Insulin Resistance to Prevalence and Progression of Coronary Artery Calcification Beyond Metabolic Syndrome in a General Population. Yamazoe, Masahiro, et al., et al. [ed.] Joseph Loscalzo. Suppl 1, Boston: American Heart Association, Inc., March 1, 2016, Circulation, Vol. 133, p. Abstract MP73. American Heart Association's Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2016 Scientific Sessions. ISSN: 0009-7322.
  95. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Knapen, M.H.J., et al., et al. [ed.] Christian Weber and Gregory Y.H. Lip. 5, Munich; Birmingham: Schattauer Publishers, May 2015, Thrombosis and Haemostasis, Vol. 113, pp. 1135-1144. DOI: 10.1160/TH14-08-0675; https://th.schattauer.de/contents/archive/issue/2210/manuscript/24032.html. ISSN: 0340-6245.
  96. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5. Kurnatowska, Ilona, et al., et al. [ed.] Anetta Undas. 9, Kraków: Medycyna Praktyczna, July 15, 2015, Polish Archives of Internal Medicine, Vol. 125, pp. 631-640. ISSN: 0032-3772.
  97. Impact of menaquinone-4 supplementation on coronary artery calcification and arterial stiffness: an open label single arm study. Ikari, Yuji, et al., et al. [ed.] Nehme Gabriel. 53, Leesburg: BioMed Central Ltd, May 12, 2016, Nutrition Journal, Vol. 15. DOI: 10.1186/s12937-016-0175-8; https://nutritionj.biomedcentral.com/articles/10.1186/s12937-016-0175-8. ISSN: 1475-2891.
  98. Vitamin K Supplementation Slows the Progression of Aortic Valve Calcification. Koos, Ralf, et al., et al. [ed.] Joseph Loscalzo. Suppl 22, Boston: American Heart Association, Inc., November 26, 2013, Circulation, Vol. 128, p. Abstract 10572. ISSN: 0009-7322.
  99. The Association of Vitamin K Intake and Status With the Metabolic Syndrome: A 10 Year Follow-Up Study. Veerle Dam, Geertje W. Dalmeijer, et al., et al. [ed.] Joseph Loscalzo. Suppl 1, Boston: American Heart Association, Inc., March 10, 2015, Circulation, Vol. 131, p. Abstract P308. ISSN: 0009-7322.
  100. Plasma proteins and vitamin K (PIVKA-II) status in school aged children in Nepal. Lee, Sun Eun, et al., et al. [ed.] Gerald Weissmann. 1 Supplement 804.22, New York: Federation of American Societies for Experimental Biology, April 2014, The FASEB Journal, Vol. 28. ISSN: 0892-6638.
  101. An Innovative Acupuncture Treatment for Primary Dysmenorrhea: A Randomized, Crossover Pilot Study. Chao, Maria T., et al., et al. [ed.] Andrew W. Campbell. 1, Houston: InnoVision Health Media, January 2014, Alternative Therapies in Health and Medicine, Vol. 20, pp. 49-56. PMCID: PMC3898591; NIHMSID: NIHMS467642. ISSN: 1078-6791.
  102. Macroalgae in Nutricosmetics. Fitton, J.H. and Irhimeh, M. [ed.] Rachel Chapman. 5, Carol Stream: Allured Publishing Corporation, May 2008, Cosmetics & Toiletries®, Vol. 123, pp. 93-100. ISSN: 0361-4387.
  103. Comparison of age-related changes in wrinkling and sagging of the skin in Caucasian females and in Japanese females. Tsukahara, K., et al., et al. [ed.] Anthony V. Rawlings. 6, London: John Wiley & Sons, Inc.: Society of Cosmetic Scientists and the Société Française de Cosmétologie, December 2004, International Journal of Cosmetic Science, Vol. 26, p. 313. DOI: 10.1111/j.1467-2494.2004.00245_5.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1467-2494.2004.00245_5.x/abstract. eISSN: 1468-2494.
  104. Paul, Cristiana. Vitamin K. [ed.] Joseph E. Pizzorno and Michael T. Murray. Textbook of Natural Medicine. 4th. St. Louis: Churchill Livingstone, an imprint of Elsevier Inc., 2013, 136, pp. 1102-1127. ISBN-13: 978-1-4377-2333-5.
  105. Vitamin K and the Nervous System: An Overview of its Actions. Ferland, Guylaine. [ed.] John W. Suttie. 2, Madison: American Society for Nutrition, March 2012, Advances in Nutrition, Vol. 3, pp. 204-212. DOI: 10.3945/an.111.001784; http://advances.nutrition.org/content/3/2/204. eISSN: 2156-5376.
  106. Vitamin K status and cognitive function in healthy older adults. Presse, Nancy, et al., et al. [ed.] Paul D. Coleman. 12, Rochester: Elsevier Inc., December http://www.sciencedirect.com/science/journal/01974580/34/12, 2013, Neurobiology of Aging, Vol. 34, pp. 2777-2783. DOI: 10.1016/j.neurobiolaging.2013.05.031; http://www.neurobiologyofaging.org/article/S0197-4580(13)00244-3/abstract. ISSN: 0197-4580.
  107. Baumann, Leslie S. The Skin Type Solution: A Revolutionary Guide to Your Best Skin Ever. New York: Bantom Books, an imprint of The Random House Publishing Group, 2006. ISBN: 978-0-553-38330-0.
  108. The effects of topical application of phytonadione, retinol and vitamins C and E on infraorbital dark circles and wrinkles of the lower eyelids. Mitsuishi, T., et al., et al. [ed.] Christopher Rowland Payne. 2, London: John Wiley & Sons, Inc., April 2004, Journal of Cosmetic Dermatology, Vol. 3, pp. 73-75. DOI: 10.1111/j.1473-2130.2004.00070.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1473-2130.2004.00070.x/abstract. eISSN: 1473-2165.
  109. Evaluation of the clinical efficacy and safety of an eye counter pad containing caffeine and vitamin K in emulsified Emu oil base. Ahmadraji, Fatemeh and Shatalebi, Mohammad Ali. [ed.] Shaghayegh Haghjooy Javanmard. 10, Isfahan: Wolters Kluwer - Medknow, January 6, 2015, Advanced Biomedical Research, Vol. 4. DOI: 10.4103/2277-9175.148292; http://www.advbiores.net/article.asp?issn=2277-9175;year=2015;volume=4;issue=1;spage=10;epage=10;aulast=Ahmadraji. eISSN: 2277-9175.
  110. Begoun, Paula. The Complete Beauty Bible: The Ultimate Guide to Smart Beauty. [ed.] Sigrid Asmus, John Hopper and Jennifer Forbes Provo. Emmaus: Rodale Inc., 2004. ISBN: 1-57954-999-3.
  111. The Role of Topical Vitamin K Oxide Gel in the Resolution of Postprocedural Purpura. Cohen, Joel Lee and Bhatia, Ashish C. [ed.] Perry Robins. 11, New York: Journal of Drugs in Dermatology, Inc., November 1, 2009, Journal of Drugs in Dermatology, Vol. 8, pp. 1020-1024. ISSN: 1545-9616.
  112. Emerging Issues in Vitamin K Research. Truong, Jennifer T., Mayer, Jean and Booth, Sarah L. [ed.] Roger A. Brumback. 1, Omaha: SAGE Publications, January 2011, Journal of Evidence-Based Complementary & Alternative Medicine, Vol. 16, pp. 73-79. ISSN: 2156-5872.
  113. Behcet's Syndrome and Vitamin K. Prosser, E.W. Cambridge: BMJ Publishing Group Ltd, March 15, 1947, British Medical Journal, p. 353. eISSN: 1756-1833.
  114. The Treatment of Diamondback Rattlesnake Bite (Crotalus Adamanteus): Vitamin K an Adjunct . Andrews, Carl E. 5, s.l.: American Medical Association, November 1960, JAMA Surgery, Vol. 81, pp. 699-705. DOI: 10.1001/archsurg.1960.01300050021004; http://archsurg.jamanetwork.com/article.aspx?articleid=559033. ISSN: 2168-6254.
  115. Vitamins and photoaging: Do scientific data support their use?. Zussman, Jamie, Ahdout, Jennifer and Kim, Jenny. [ed.] Bruce H. Thiers. 3, Charleston: Elsevier Inc., September 2010, Journal of the American Academy of Dermatology, Vol. 63, pp. 507-525. DOI: 10.1016/j.jaad.2009.07.037; http://www.jaad.org/article/S0190-9622(09)00959-1/abstract. ISSN: 0190-9622.
  116. Effects of Topical Vitamin K and Retinol on Laser-Induced Purpura on Nonlesional Skin. Lou, Wendy W., et al., et al. [ed.] Ronald L. Moy. 12, Los Angeles: Wiley Periodicals, Inc., December 1999, Dermatologic Surgery, Vol. 25, pp. 942-944. DOI: 10.1046/j.1524-4725.1999.99145.x; http://journals.lww.com/dermatologicsurgery/pages/articleviewer.aspx?year=1999&issue=12000&article=00006&type=abstract. ISSN: 1076-0512.
  117. How vitamin K gels treat postoperative bruising. Karavani, I. s.l.: AYA Productions, November 2004, Body Language Dermatology, Vol. 6, pp. 14-16.
  118. The Study on the Efficacy of Topical Vitamin K Versus 5% Urea on Laser-induced Purpura. Srisuttiyakorn, Chutika, Vathanasantij, Achara and Kanechorn-Na-Ayuthaya, Pinyapat. [ed.] Georgi Tchernev and Hsuan-Hsiang Chen. 2, Sofia; Taipei City: Symbiosis Open Journals, March 19, 2016, Clinical Research in Dermatology, Vol. 3, pp. 1-3. eISSN: 2378-1726.
  119. Menadione (vitamin K) enhances the antibiotic activity of drugs by cell membrane permeabilization mechanism. Andrade, Jacqueline C., et al., et al. [ed.] Abdullah S. Alhomida. Riyadh: Elsevier B.V.: King Saud University, October 21, 2015, Saudi Journal of Biological Sciences. DOI: 10.1016/j.sjbs.2015.09.004; http://www.sciencedirect.com/science/article/pii/S1319562X15001990. ISSN: 1319-562X.
  120. Proteins Invoked by Vitamin K Absence and Clotting Times in Clinically Ill Cats. Center, S.A., et al., et al. [ed.] Stephen P. DiBartola and Kenneth W. Hinchcliff. 3, Columbus; Melbourne: John Wiley & Sons, Inc., May 2000, Journal of Veterinary Internal Medicine, Vol. 14, pp. 292-297. DOI: 10.1111/j.1939-1676.2000.tb01169.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1939-1676.2000.tb01169.x/abstract. ISSN: 0891-6640.
  121. Probable Vitamin K-Deficient Bleeding in Two Cats With Malabsorption Syndrome Secondary to Lymphocytic-Plasmacytic Enteritis. Edwards, David F. and Russell, Robert G. [ed.] Alfred M. Legendre. 3, Knoxville: J.B. Lippincott Company, 1987, Journal of Veterinary Internal Medicine, Vol. 1, pp. 97-101. ISSN: 0891-6640.
  122. Anticoagulant Rodenticide Intoxication in Animals - A Review. Valchev, Ivan, et al., et al. 4, s.l.: TÜBİTAK Academic Journals, 2008, Turkish Journal of Veterinary Animal Science, Vol. 32, pp. 237-243. eISSN: 1303-6181.
  123. Coagulopathic Effects and Therapy of Brodifacoum Toxicosis in Dogs. Woody, Benny J., et al., et al. [ed.] Alfred M. Legendre. 1, Knoxville: J.B. Lippincott Company, January 1992, Journal of Veterinary Internal Medicine, Vol. 6, pp. 23-28. DOI: 10.1111/j.1939-1676.1992.tb00981.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1939-1676.1992.tb00981.x/abstract. ISSN: 0891-6640.
  124. Anticoagulant rodenticide toxicity in 21 dogs. Sheafor, S.E. and Couto, C.G. 1, s.l.: American Animal Hospital Association, January/February 1999, Journal of the American Animal Hospital Association, Vol. 35, pp. 38-46. DOI: 10.5326/15473317-35-1-38; http://jaaha.org/doi/abs/10.5326/15473317-35-1-38. eISSN: 1547-3317.
  125. Vitamin K treatment of sweet clover poisoning in calves. Alstad, A.D., Casper, H.H. and Johnson, L.J. [ed.] Albert J. Koltveit. 7, Schaumburg: American Veterinary Medical Association, October 1, 1985, Journal of the American Veterinary Medical Association, Vol. 187, pp. 729-731. ISSN: 0003-1488.
  126. Stegelmeier, Bryan L. Overview of Sweet Clover Poisoning. The Merck Veterinary Manual. [Online] February 2014. [Cited: August 28, 2016.] http://www.merckvetmanual.com/mvm/toxicology/sweet_clover_poisoning/overview_of_sweet_clover_poisoning.html.
  127. Effects of a single intramuscular injection of vitamin K on the hematology, serum biochemistry and coagulation parameters in healthy adult dairy cows. Ismail, Zuhair Bani, et al., et al. [ed.] Lazo Pendovski. 2, Skopje: Walter de Gruyter GmbH, October 15, 2016, Macedonian Veterinary Review, Vol. 39, pp. 1-4. ISSN: 1857-7425.
  128. Evaluation of Vitamin K3 Feed Additive for Prevention of Sweet Clover Disease. Casper, Howard H., et al., et al. 2, s.l.: SAGE Publications, April 1989, Journal of Veterinary Diagnostic Investigation, Vol. 1, pp. 116-119. DOI: 10.1177/104063878900100204; http://vdi.sagepub.com/content/1/2/116. ISSN: 1040-6387.
  129. Bone structure and strength at different ages in laying hens and effects of dietary particulate limestone, vitamin K and ascorbic acid. Fleming, R.H., McCormack, H.A. and Whitehead, C.C. [ed.] B.O. Hughes and J.M. McNab. 3, Roslin: Taylor & Francis Online, 1998, British Poultry Science, Vol. 39, pp. 434-440. DOI: 10.1080/00071669889024; http://www.tandfonline.com/doi/abs/10.1080/00071669889024. ISSN: 0007-1668.
  130. Ellis, Ralph and Sidner, Sara. Prince died of accidental overdose of opioid fentanyl, medical examiner says. s.l.: CNN, 2016. News.
  131. Experimental Study of the Effect of Vitamin K3 on the Pharmacological Action of Fentanyl. Chi, Mo, Zichi, Tan and Lingqing, Tan. [ed.] Jian-guo Xu. Nanjing: Nanjing Branch of the Chinese Medical Association, January 1998, The Journal of Clinical Anesthesiology. ISSN: 1004-5805.
Disclaimer: This website is not intended to replace professional consultation, diagnosis, or treatment by a licensed physician. If you require any medical related advice, contact your physician promptly. Information presented on this website is exclusively of a general reference nature. Do not disregard medical advice or delay treatment as a result of accessing information at this site.